Gold-Catalyzed Asymmetric Synthesis of Cyclic and Heterocyclic Structures
This research community focuses on using gold, silver, and rhodium catalysts to build complex, three-dimensional organic molecules, specifically targeting the creation of chiral centers and strained ring systems for pharmaceutical and materials applications.
The work centers on the catalytic activation of alkynes, diazo compounds, and allenes to drive cyclization, carbene insertion, and cascade reactions. Recurring themes include the development of chiral ligands to achieve enantioselective synthesis, the manipulation of donor-acceptor cyclopropanes, and the construction of medium-sized rings and spirocycles. Specific methods involve gold-catalyzed C-H activation, tandem reactions, and the asymmetric functionalization of terminal alkynes. The community also explores the role of N-heterocyclic carbenes and the interplay between gold(I) and gold(III) oxidation states to control reaction pathways and molecular diversity.
The largest share of the community's output is found in gold research, accounting for 2.1% of all gold-related papers, with 4,814 papers in this group. Rhodium research represents the next largest share at 3.7%, comprising 1,340 papers, while silver research contributes 0.6% with 1,185 papers.
The community comprises 12,481 papers, primarily published in Organic Letters, The Journal of Organic Chemistry, and the Journal of the American Chemical Society.
Recent work highlights the application of these methods in medicinal chemistry, including the synthesis of fused-cyclopropanes and heterospirocycles, as well as advances in enantioselective dearomative reactions and gold-catalyzed C-P cross-couplings.